A cleanser formulated with Tris (hydroxymethyl) aminomethane and l-arginine significantly improves facial acne in male Thai subjects.


Journal

Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 05 02 2019
revised: 26 04 2019
accepted: 27 06 2019
pubmed: 28 7 2019
medline: 20 1 2021
entrez: 27 7 2019
Statut: ppublish

Résumé

Acne is one of the most common skin problems among human populations. A facial cleanser formulated with alkyl ether carboxylate (AEC) and alkyl carboxylate (AC) can improve acne by cleansing sebum on facial skin but cannot effectively remove keratotic plugs in the skin pores. Recently, we confirmed that Tris (hydroxymethyl) aminomethane and L-arginine (Tris/Arg) is able to reduce sebum levels, disrupt keratotic plugs in vitro and decrease pore size on facial skin. To compare the efficacy of the Tris/Arg-formulated cleanser with the AEC/AC cleanser in Thai subjects with acne. We designed a randomized, double-blind, controlled, parallel trial. Thirty-four male Thai subjects with mild to moderate acne were assigned to one of two groups: one group used the Tris/Arg cleanser while the other used the AEC/AC-based cleanser twice a day for 4 weeks. After 4 weeks, significant decreases in noninflammatory acne were observed in both groups, yet significant decreases in inflammatory acne were only observed in the Tris/Arg cleanser group. The sebum level prior to and 30 minutes after facial washing showed no change in either group. The average pore size with keratotic plugs on the cheeks was significantly decreased in the Tris/Arg group. More than half of subjects in both groups observed acne improvement but more subjects in the Tris/Arg group noted pore size improvement. The Tris/Arg formulated cleanser has a high efficacy for significantly reducing both noninflammatory and inflammatory acne accompanied by decreases in pore size with keratotic plugs in male Thai subjects.

Sections du résumé

BACKGROUND BACKGROUND
Acne is one of the most common skin problems among human populations. A facial cleanser formulated with alkyl ether carboxylate (AEC) and alkyl carboxylate (AC) can improve acne by cleansing sebum on facial skin but cannot effectively remove keratotic plugs in the skin pores. Recently, we confirmed that Tris (hydroxymethyl) aminomethane and L-arginine (Tris/Arg) is able to reduce sebum levels, disrupt keratotic plugs in vitro and decrease pore size on facial skin.
OBJECTIVE OBJECTIVE
To compare the efficacy of the Tris/Arg-formulated cleanser with the AEC/AC cleanser in Thai subjects with acne.
METHODS METHODS
We designed a randomized, double-blind, controlled, parallel trial. Thirty-four male Thai subjects with mild to moderate acne were assigned to one of two groups: one group used the Tris/Arg cleanser while the other used the AEC/AC-based cleanser twice a day for 4 weeks.
RESULTS RESULTS
After 4 weeks, significant decreases in noninflammatory acne were observed in both groups, yet significant decreases in inflammatory acne were only observed in the Tris/Arg cleanser group. The sebum level prior to and 30 minutes after facial washing showed no change in either group. The average pore size with keratotic plugs on the cheeks was significantly decreased in the Tris/Arg group. More than half of subjects in both groups observed acne improvement but more subjects in the Tris/Arg group noted pore size improvement.
CONCLUSION CONCLUSIONS
The Tris/Arg formulated cleanser has a high efficacy for significantly reducing both noninflammatory and inflammatory acne accompanied by decreases in pore size with keratotic plugs in male Thai subjects.

Identifiants

pubmed: 31347768
doi: 10.1111/jocd.13087
doi:

Substances chimiques

Carboxylic Acids 0
Cosmeceuticals 0
Tromethamine 023C2WHX2V
Arginine 94ZLA3W45F

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

901-909

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Stoughton RB, Leyden JJ. Efficacy of 4 percent chlorhexidine gluconate skin cleanser in the treatment of acne vulgaris. Cutis. 1987;39:551-553.
Kurokawa I, Danby FW, Ju Q, et al. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol. 2009;18:821-832.
Jugeau S, Tenaud I, Knol AC, et al. Induction of toll-like receptors by Propionibacterium acnes. Br J Dermatol. 2005;153:1105-1113.
Zaenglein AL, Thiboutot CM. Acne Vulgaris and Related Disorders. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Edinburgh, Scotland: Mosby; 2003:531-544.
Burkhart CG, Burkhart CN. Expanding the microcomedone theory and acne therapeutics: propionibacterium acnes biofilm produces biological glue that holds corneocytes together to form plug. J Am Acad Dermatol. 2007;57:722-724.
Choi CW, Choi JW, Park KC, Youn SW. Facial sebum affects the development of acne, especially the distribution of inflammatory acne. J Eur Acad Dermatol Venereol. 2013;27:301-306.
Guo JW, Lin TK, Wu CH, et al. Human sebum extract induces barrier disruption and cytokine expression in murine epidermis. J Dermatol Sci. 2015;78:34-43.
Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74:945-973.
Ozawa T, Miyaki M. Skin Cleanser Composition. Japanese Patent. 2009;JP2009275012.
Ozawa T. Development of the new skin cleansing technology with mildness to skin and high cleansing ability. Fragrance J. 2012;8:21-25.
Isoda K, Takagi Y, Endo K, et al. Effects of washing of the face with a mild facial cleanser formulated with alkyl ether carboxylate and alkyl carboxylates on acne in Japanese adult males. Skin Res Technol. 2015;21:247-253.
Sampuntharat J, Boonkoom P, Takagi Y, et al. An alkyl ether carboxylate and alkyl carboxylate formulated cleanser decreases facial sebum and inflammatory acne without inducing dry xerotic skin in Thai females. Int J Clin Dermatol Res. 2015;3:60-64.
Ozawa T, Sakai T, Miyoshi M, Furukara D, Shirai A. Keratin plug removal method. WO Patent. 2018;WO:190301.
Nordstrom KM, Labows JN, McGinley KJ, Leyden JJ. Characterization of wax esters, triglycerides, and free fatty acids of follicular casts. J Invest Dermatol. 1986;86:700-705.
Hayashi N, Akamatsu H, Kawashima M. Acne Study Group. Establishment of grading criteria for acne severity. J Dermatol. 2008;35:255-260.
Choi JM, Lew VK, Kimball AB. A single-blinded, randomized, controlled clinical trial evaluating the effect of face washing on acne vulgaris. Pediatr Dermatol. 2006;23:421-427.
Sweeney TM, Szarnicki RJ, Strauss JS, Pochi PE. The effect of estrogen and androgen on the sebaceous gland turnover time. J Invest Dermatol. 1969;53:8-10.
Zachariae H. Topical vitamin-A-acid in acne. Acta derm venereol suppl (Stockh). 1980;Suppl 89:65-70.
Deplewski D, Rosenfield RL. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology. 1999;140:4089-4094.
Trivedi NR, Cong Z, Nelson AM, et al. Peroxisome proliferator-activated receptors increase human sebum production. J Invest Dermatol. 2006;126:2002-2009.
Hong I, Lee MH, Na TY, Zouboulis CC, Lee MO. LXR alpha enhances lipid synthesis in SZ95 sebocytes. J Invest Dermatol. 2008;128:1266-1272.
Draelos ZD. The effect of a daily facial cleanser for normal to oily skin on the skin barrier of subjects with acne. Cutis. 2006;78(Suppl):34-40.
Yokoi A, Endo K, Ozawa T, et al. A cleanser based on sodium laureth carboxylate and alkyl carboxylates washes facial sebum well but does not induce dry skin. J Cosmet Dermatol. 2014;13:245-252.

Auteurs

Chanat Kumtornrut (C)

Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.

Siyarat Dilokphongyotin Manabe (SD)

Kao Consumer Products, Bangkok, Thailand.

Marut Navapongsiri (M)

Kao Consumer Products, Bangkok, Thailand.

Yuri Okutani (Y)

Kao Corporation, Tokyo, Japan.

Shinichi Ikegaki (S)

Kao Corporation, Tokyo, Japan.

Noriyuki Tanaka (N)

Kao Consumer Products, Bangkok, Thailand.

Hiroshi Hashimoto (H)

Kao Corporation, Tokyo, Japan.

Chankiat Songsantiphap (C)

Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.

Kittipong Wantavornprasert (K)

Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.

Jenvajee Khamthara (J)

Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.

Yutaka Takagi (Y)

Kao Corporation, Tokyo, Japan.

Pravit Asawanonda (P)

Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH